BBL
CVS icon

Beck Bode LLC’s CVS Health CVS Stock Holding History

Beck Bode LLC’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8M Sell
77,309
-487
-0.6% -$43.5K 1.21% 29
2026
Q1 		$5.59M Buy
+77,796
New +$5.99M 0.95% 36
2023
Q1 		– Sell
-10,631
Closed -$991K – 149
2022
Q4 		$991K Sell
10,631
-598
-5% -$57.7K 0.22% 96
2022
Q3 		$1.07M Buy
11,229
+510
+5% +$50.5K 0.23% 94
2022
Q2 		$993K Sell
10,719
-8,807
-45% -$860K 0.21% 88
2022
Q1 		$1.98M Buy
19,526
+881
+5% +$92.6K 0.45% 49
2021
Q4 		$1.92M Buy
18,645
+2,046
+12% +$189K 0.48% 43
2021
Q3 		$1.41M Buy
16,599
+717
+5% +$60.1K 0.39% 47
2021
Q2 		$1.32M Buy
15,882
+13,152
+482% +$1.08M 0.37% 42
2021
Q1 		$205K Buy
+2,730
New +$199K 0.06% 67
2020
Q4 		– Sell
-131,020
Closed -$7.65M – 69
2020
Q3 		$7.65M Buy
131,020
+11,577
+10% +$720K 2.77% 19
2020
Q2 		$7.76M Buy
119,443
+11,499
+11% +$724K 3.18% 16
2020
Q1 		$6.64M Buy
107,944
+101,829
+1,665% +$6.8M 3.05% 17
2019
Q4 		$454K Sell
6,115
-317
-5% -$22.3K 0.19% 55
2019
Q3 		$406K Buy
6,432
+265
+4% +$15.7K 0.18% 57
2019
Q2 		$336K Sell
6,167
-681
-10% -$36.7K 0.15% 55
2019
Q1 		$369K Sell
6,848
-72,035
-91% -$4.45M 0.18% 55
2018
Q4 		$5.17M Buy
+78,883
New +$5.89M 2.81% 15

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Beck Bode LLC's CVS Position: Q2 2026 in Review

Beck Bode LLC reduced its CVS Health (CVS) stake by 0.63% in Q2 2026, selling an estimated $43.5K and leaving 77,309 shares worth $8M. The position accounts for 1.21% of the portfolio, ranked #29.

Beck Bode LLC first reported a position in CVS in Q4 2018 and has held it in 18 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Beck Bode LLC held 77,309 shares of CVS Health worth $8M as of Q2 2026.
  • Beck Bode LLC sold 487 CVS Health shares in Q2 2026, an estimated $43.5K.
  • CVS Health made up 1.21% of Beck Bode LLC's portfolio in Q2 2026, its #29 holding.
  • Beck Bode LLC first reported a position in CVS Health in Q4 2018 and has held it in 18 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Beck Bode LLC's 13F filing for Q2 2026, filed 13 Aug 2026.